Cassie Lane

Cassie Lane is an accomplished clinical development scientist with extensive experience in the biopharmaceutical industry. Currently serving as the Director of Clinical Development Scientist at Alterome Therapeutics, Inc. since August 2025, Cassie previously held the position of Senior Clinical Scientist and Clinical Science Lead at Bristol Myers Squibb following the acquisition of Mirati Therapeutics. While at Mirati Therapeutics, Cassie progressed from Director to Senior Director of Clinical Development Scientist. Prior experience includes directorial and managerial roles at Sarah Cannon and the Sarah Cannon Research Institute, where Cassie gained significant expertise in clinical development and analytics. Cassie Lane holds a Master of Science in Research and Experimental Psychology and a Bachelor of Science in Biology and Psychology, both from The University of Tennessee at Chattanooga.